Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2007

01-09-2007 | Article

Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome

Authors: M. F. Seidel, A. Belda Domene, H. Vetter

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2007

Login to get access

Abstract

The symptoms of Lyme borreliosis are similar to those of a variety of autoimmune musculoskeletal diseases. Persistence of complaints is frequently interpreted as unsuccessful antibiotic treatment of Borrelia-associated infections. However, such refractory cases are rare, and re-evaluation of differential diagnoses helps to avoid the substantial risk of long-term antibiotic therapy. In this study, we analyzed patients who presented to our rheumatology unit with previous suspected or diagnosed Lyme borreliosis. Eighty-six patients from a 3.5-year period were evaluated. The mean age of patients was 49.2 ± 17.2 years; 60% (n = 52) reported a tick bite and 33% (n = 28) an erythema. Forty-seven percent (n = 39) had positive enzyme-linked immunoassay results and Western blots (Mikrogen, Martinsried, Germany). All but 12 patients had already received antibiotic treatment previously. Nine percent (n = 8) had ongoing or recent Lyme borreliosis. Twenty-nine percent (n = 25) showed clinical symptoms and radiographic changes compatible with degenerative disorders of the cervical and/or lumbar spine. These patients were significantly older when compared to the other patients (59.3 ± 13.7 years vs 46.1 ± 17.2 years, p = 0.001). Seventeen percent (n = 16) had arthropathies related to psoriasis or rheumatoid arthritis. Twelve percent (n = 10) were positive for the HLA B27 antigen. Other diseases were less frequent. Six patients (7%) could not be diagnosed conclusively, and four of these patients had negative Borrelia immunoassay results. In conclusion, Borrelia-associated diseases were rare in this study. Differential diagnoses helped to initiate a successful disease-specific therapeutic strategy.
Literature
1.
go back to reference Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC et al (2000) Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 31(Suppl 1):1–14PubMedCrossRef Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC et al (2000) Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 31(Suppl 1):1–14PubMedCrossRef
2.
go back to reference Oksi J, Nikoskelainen J, Viljanen MK (1998) Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis. Eur J Clin Microbiol Infect Dis 17:715–719PubMedCrossRef Oksi J, Nikoskelainen J, Viljanen MK (1998) Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis. Eur J Clin Microbiol Infect Dis 17:715–719PubMedCrossRef
3.
go back to reference Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85–92PubMedCrossRef Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85–92PubMedCrossRef
4.
go back to reference Hunfeld KP, Ruzic-Sabljic E, Norris DE, Kraiczy P, Strle F (2005) In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob Agents Chemother 49:1294–1301PubMedCrossRef Hunfeld KP, Ruzic-Sabljic E, Norris DE, Kraiczy P, Strle F (2005) In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob Agents Chemother 49:1294–1301PubMedCrossRef
5.
go back to reference Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A (1998) Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 57:118–121PubMedCrossRef Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A (1998) Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 57:118–121PubMedCrossRef
6.
go back to reference Hassler D, Zoller L, Haude M, Hufnagel HD, Heinrich F, Sonntag HG (1990) Cefotaxime versus penicillin in the late stage of Lyme disease—prospective, randomized therapeutic study. Infection 18:16–20PubMedCrossRef Hassler D, Zoller L, Haude M, Hufnagel HD, Heinrich F, Sonntag HG (1990) Cefotaxime versus penicillin in the late stage of Lyme disease—prospective, randomized therapeutic study. Infection 18:16–20PubMedCrossRef
7.
go back to reference Hassler D, Schnauffer M, Ehrfeld H, Muller E (2004) Disappearance of specific immune response after successful therapy of chronic Lyme borreliosis. Int J Med Microbiol 293(Suppl 37):161–164PubMed Hassler D, Schnauffer M, Ehrfeld H, Muller E (2004) Disappearance of specific immune response after successful therapy of chronic Lyme borreliosis. Int J Med Microbiol 293(Suppl 37):161–164PubMed
8.
go back to reference Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double-masked clinical trial. Neurology 60:1923–1930PubMed Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double-masked clinical trial. Neurology 60:1923–1930PubMed
9.
go back to reference Wormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P et al (2003) Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:697–704PubMed Wormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P et al (2003) Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:697–704PubMed
10.
go back to reference Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM (2000) Death from inappropriate therapy for Lyme disease. Clin Infect Dis 31:1107–1109PubMedCrossRef Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM (2000) Death from inappropriate therapy for Lyme disease. Clin Infect Dis 31:1107–1109PubMedCrossRef
11.
go back to reference Bolz DD, Weis JJ (2004) Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?. Autoimmunity 37:387–392PubMedCrossRef Bolz DD, Weis JJ (2004) Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?. Autoimmunity 37:387–392PubMedCrossRef
12.
go back to reference Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA et al (1998) Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281:703–706PubMedCrossRef Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA et al (1998) Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281:703–706PubMedCrossRef
13.
go back to reference Kalish RS, Wood JA, Golde W, Bernard R, Davis LE, Grimson RC et al (2003) Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status. J Infect Dis 187:102–108PubMedCrossRef Kalish RS, Wood JA, Golde W, Bernard R, Davis LE, Grimson RC et al (2003) Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status. J Infect Dis 187:102–108PubMedCrossRef
15.
go back to reference Wormser GP, Aguero-Rosenfeld ME, Nadelman RB (1999) Lyme disease serology problems and opportunities. JAMA 282:79–80PubMedCrossRef Wormser GP, Aguero-Rosenfeld ME, Nadelman RB (1999) Lyme disease serology problems and opportunities. JAMA 282:79–80PubMedCrossRef
16.
go back to reference Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC (2001) Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10 to 20 years after active Lyme disease. Clin Infect Dis 33:780–785PubMedCrossRef Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC (2001) Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10 to 20 years after active Lyme disease. Clin Infect Dis 33:780–785PubMedCrossRef
17.
go back to reference Werner M, Nordin P, Arnholm B, Elgefors B, Krantz I (2001) Borrelia burgdorferi antibodies in outdoor and indoor workers in south-west Sweden. Scand J Infect Dis 33:128–131PubMedCrossRef Werner M, Nordin P, Arnholm B, Elgefors B, Krantz I (2001) Borrelia burgdorferi antibodies in outdoor and indoor workers in south-west Sweden. Scand J Infect Dis 33:128–131PubMedCrossRef
18.
go back to reference Qureshi MZ, New D, Zulqarni NJ, Nachman S (2002) Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 21:12–14PubMedCrossRef Qureshi MZ, New D, Zulqarni NJ, Nachman S (2002) Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 21:12–14PubMedCrossRef
19.
20.
go back to reference Rose CD, Fawcett PT, Gibney KM, Doughty RA (1994) The overdiagnosis of Lyme disease in children residing in an endemic area. Clin Pediatr (Phila) 33:663–668CrossRef Rose CD, Fawcett PT, Gibney KM, Doughty RA (1994) The overdiagnosis of Lyme disease in children residing in an endemic area. Clin Pediatr (Phila) 33:663–668CrossRef
21.
go back to reference Hsu VM, Patella SJ, Sigal LH (1993) “Chronic Lyme disease” as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum 36:1493–1500PubMedCrossRef Hsu VM, Patella SJ, Sigal LH (1993) “Chronic Lyme disease” as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum 36:1493–1500PubMedCrossRef
22.
go back to reference Sigal LH, Patella SJ (1992) Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics 90:523–528PubMed Sigal LH, Patella SJ (1992) Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics 90:523–528PubMed
23.
go back to reference Steere AC, Taylor E, McHugh GL, Logigian EL (1993) The overdiagnosis of Lyme disease. JAMA 269:1812–1816PubMedCrossRef Steere AC, Taylor E, McHugh GL, Logigian EL (1993) The overdiagnosis of Lyme disease. JAMA 269:1812–1816PubMedCrossRef
24.
go back to reference Renaud I, Cachin C, Gerster JC (2004) Good outcomes of Lyme arthritis in 24 patients in an endemic area of Switzerland. Jt Bone Spine 71:39–43CrossRef Renaud I, Cachin C, Gerster JC (2004) Good outcomes of Lyme arthritis in 24 patients in an endemic area of Switzerland. Jt Bone Spine 71:39–43CrossRef
25.
go back to reference Hauser U, Lehnert G, Lobentanzer R, Wilske B (1997) Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 35:1433–1444PubMed Hauser U, Lehnert G, Lobentanzer R, Wilske B (1997) Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 35:1433–1444PubMed
26.
go back to reference Hauser U, Lehnert G, Wilske B (1999) Validity of interpretation criteria for standardized Western blots (immunoblots) for the serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 37:2241–2247PubMed Hauser U, Lehnert G, Wilske B (1999) Validity of interpretation criteria for standardized Western blots (immunoblots) for the serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 37:2241–2247PubMed
27.
go back to reference Fournie B, Crognier L, Arnaud C, Zabraniecki L, Lascaux-Lefebvre V, Marc V et al (1999) Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rhum Engl 66:446–456 Fournie B, Crognier L, Arnaud C, Zabraniecki L, Lascaux-Lefebvre V, Marc V et al (1999) Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rhum Engl 66:446–456
28.
go back to reference Goie The HS, Steven MM, van der Linden SM, Cats A (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24(3):242–249PubMedCrossRef Goie The HS, Steven MM, van der Linden SM, Cats A (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24(3):242–249PubMedCrossRef
29.
go back to reference Nahimana I, Gern L, Peter O, Praz G, Moosmann Y, Francioli P (2000) Epidemiology of Lyme borreliosis in French-speaking Switzerland. Schweiz Med Wochenschr 130:1456–1461PubMed Nahimana I, Gern L, Peter O, Praz G, Moosmann Y, Francioli P (2000) Epidemiology of Lyme borreliosis in French-speaking Switzerland. Schweiz Med Wochenschr 130:1456–1461PubMed
30.
go back to reference Marguet C, Rouillier-Saas M, Mallet E, Meunier M, Jeannot E, Boulloche J et al (2000) Lyme disease in Upper Normandy: report of a hospital. Arch Pediatr 7(Suppl 3):517–522CrossRef Marguet C, Rouillier-Saas M, Mallet E, Meunier M, Jeannot E, Boulloche J et al (2000) Lyme disease in Upper Normandy: report of a hospital. Arch Pediatr 7(Suppl 3):517–522CrossRef
31.
go back to reference Woodrum JE, Oliver JH Jr (1999) Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. J Parasitol 85:426–430PubMedCrossRef Woodrum JE, Oliver JH Jr (1999) Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. J Parasitol 85:426–430PubMedCrossRef
32.
go back to reference Weiss NL, Sadock VA, Sigal LH, Phillips M, Merryman PF, Abramson SB (1995) False-positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis. Lupus 4:131–137PubMed Weiss NL, Sadock VA, Sigal LH, Phillips M, Merryman PF, Abramson SB (1995) False-positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis. Lupus 4:131–137PubMed
33.
go back to reference Rawlins ML, Gerstner C, Hill HR, Litwin CM (2005) Evaluation of a Western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi. Clin Diagn Lab Immunol 12:1269–1274PubMedCrossRef Rawlins ML, Gerstner C, Hill HR, Litwin CM (2005) Evaluation of a Western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi. Clin Diagn Lab Immunol 12:1269–1274PubMedCrossRef
34.
go back to reference Hunfeld KP, Brade V (1999) Prevalence of antibodies against the human granulocytic ehrlichiosis agent in Lyme borreliosis patients from Germany. Eur J Clin Microbiol Infect Dis 18:221–224PubMedCrossRef Hunfeld KP, Brade V (1999) Prevalence of antibodies against the human granulocytic ehrlichiosis agent in Lyme borreliosis patients from Germany. Eur J Clin Microbiol Infect Dis 18:221–224PubMedCrossRef
35.
go back to reference Hunfeld KP, Allwinn R, Peters S, Kraiczy P, Brade V (1998) Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany. Wien Klin Wochenschr 110:901–908PubMed Hunfeld KP, Allwinn R, Peters S, Kraiczy P, Brade V (1998) Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany. Wien Klin Wochenschr 110:901–908PubMed
36.
go back to reference Brown SL, Hansen SL, Langone JJ (1999) Role of serology in the diagnosis of Lyme disease. JAMA 282:62–66PubMedCrossRef Brown SL, Hansen SL, Langone JJ (1999) Role of serology in the diagnosis of Lyme disease. JAMA 282:62–66PubMedCrossRef
37.
go back to reference Zhioua E, Rodhain F, Binet P, Perez-Eid C (1997) Prevalence of antibodies to Borrelia burgdorferi in forestry workers of Ile de France, France. Eur J Epidemiol 13:959–962PubMedCrossRef Zhioua E, Rodhain F, Binet P, Perez-Eid C (1997) Prevalence of antibodies to Borrelia burgdorferi in forestry workers of Ile de France, France. Eur J Epidemiol 13:959–962PubMedCrossRef
38.
go back to reference Karch H, Huppertz HI, Böhme M, Schmidt H, Wiebecke D (1994) Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol 32:2312–2314PubMed Karch H, Huppertz HI, Böhme M, Schmidt H, Wiebecke D (1994) Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol 32:2312–2314PubMed
Metadata
Title
Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome
Authors
M. F. Seidel
A. Belda Domene
H. Vetter
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2007
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0342-0

Other articles of this Issue 9/2007

European Journal of Clinical Microbiology & Infectious Diseases 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.